(a) Research for the development of well-characterized and more-defined medical marijuana products for treatment of target indications, including demonstrations of safety and efficacy for treatment of medical conditions that often fail to respond to conventional treatment, may be conducted in Delaware.
(b) Research performed under the authority of this chapter shall be conducted as follows:
(1) In a facility which meets FDA-accepted security and operational standards.
(2) Using practices and standards that ensure uniformity, consistency, reliability, reproducibility, quality, and integrity of data, including good laboratory standards (GLP) when required.
(3) On plants grown from well-characterized and well-defined seed stock.
Structure Delaware Code
Chapter 49A. THE DELAWARE MEDICAL MARIJUANA ACT
§ 4902A. Definitions [For application of this section, see 82 Del. Laws, c. 246, § 5].
§ 4903A. Protections for the medical use of marijuana.
§ 4905A. Discrimination prohibited.
§ 4906A. Addition of debilitating medical conditions.
§ 4907A. Acts not required, acts not prohibited.
§ 4912A. Notifications to Department and responses; civil penalty.
§ 4913A. Affirmative defense and dismissal for medical marijuana.
§ 4914A. Registration of compassion centers.
§ 4915A. Registration and certification of safety compliance facilities.
§ 4916A. Compassion center and safety compliance facilities renewal.
§ 4918A. Compassion center and safety compliance facility agents.
§ 4919A. Requirements, prohibitions, penalties.
§ 4921A. Registry identification and registration certificate verification.